Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

NGNE Neurogene PE ratio, current and historical analysis

The current PE ratio of NGNE cannot be calculated, as the latest EPS of -$4.35 is negative.

NGNE PE ratio history

How has NGNE's PE ratio performed in the past
Today
N/A
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A

Neurogene PE ratio by year

Year PE ratio PE change Price EPS
2024 N/A N/A $22.86 -$4.28
2023 N/A N/A $19.38 -$117.28
2022 N/A N/A $10.18 -$139.88
2021 N/A N/A $96.4 -$22
2020 N/A N/A $282 -$12.8
2019 N/A N/A $246.4 -$51.4
2018 N/A N/A $43.2 -$26.8
2017 N/A N/A $235.2 -$42.8
2016 N/A N/A $330.2 -$39.2
2015 N/A N/A $249.6 -$34.6
2014 N/A N/A $150 -$55
2013 N/A N/A N/A -$990.4
2012 N/A N/A N/A -$804.6

Neurogene PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Mar 2025 N/A N/A $11.71 -$4.35
Dec 2024 N/A N/A $22.86 -$4.28
Sep 2024 N/A N/A $41.96 -$32.9
Jun 2024 N/A N/A $36.39 -$64.38
Mar 2024 N/A N/A $50.9 -$89.97
Dec 2023 N/A N/A $19.38 -$117.28
Sep 2023 N/A N/A $15.8 -$211.55
Jun 2023 N/A N/A $16.6 -$183.6
Mar 2023 N/A N/A $14 -$162.52
Dec 2022 N/A N/A $10.18 -$139.88
Sep 2022 N/A N/A $12.8 -$21.32
Jun 2022 N/A N/A $20.6 -$22.2
Mar 2022 N/A N/A $37.6 -$22
Dec 2021 N/A N/A $96.4 -$22
Sep 2021 N/A N/A $144.6 -$21

NGNE Price vs fair value

How does NGNE's price compare to its estimated fair value based on its growth

NGNE average PE ratio chart

What is the average PE ratio of NGNE for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

NGNE PE vs peers

What is NGNE's PE ratio compared to its peers
Stock name PE ratio Market cap
OLMA Olema Pharmaceuticals Inc N/A $298.32M
OMER Omeros Corp N/A $210.93M
VIVS VivoSim Labs Inc. N/A $2.68M
ORIC Oric Pharmaceuticals Inc N/A $670.36M
ORMP Oramed Pharmaceuticals Inc N/A $88.24M
NGNE Neurogene Inc N/A $345.43M

Frequently asked questions

What is Neurogene's PE ratio?

The current price to earnings ratio of NGNE cannot be determined, as its EPS of -$4.35 is negative.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.